Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Bone Marrow Blood Vessels: Normal and Neoplastic Niche.

Shahrabi S, Rezaeeyan H, Ahmadzadeh A, Shahjahani M, Saki N.

Oncol Rev. 2016 Nov 24;10(2):306. eCollection 2016 Oct 10. Review.

2.

Suppression of Akt-HIF-1α signaling axis by diacetyl atractylodiol inhibits hypoxia-induced angiogenesis.

Choi SW, Lee KS, Lee JH, Kang HJ, Lee MJ, Kim HY, Park KI, Kim SL, Shin HK, Seo WD.

BMB Rep. 2016 Sep;49(9):508-13.

3.
4.

ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia.

Martinelli S, Kanduri M, Maffei R, Fiorcari S, Bulgarelli J, Marasca R, Rosenquist R.

Epigenetics. 2013 Jul;8(7):720-9. doi: 10.4161/epi.24947. Epub 2013 May 14.

5.

The role of vascular endothelial growth factor and matrix metalloproteinases in canine lymphoma: in vivo and in vitro study.

Aricò A, Giantin M, Gelain ME, Riondato F, Comazzi S, Rütgen BC, Essler SE, Dacasto M, Castagnaro M, Aresu L.

BMC Vet Res. 2013 May 3;9:94. doi: 10.1186/1746-6148-9-94.

6.

Effects of spironolactone and losartan on diabetic nephropathy in a type 2 diabetic rat model.

Lee MY, Shim MS, Kim BH, Hong SW, Choi R, Lee EY, Nam SM, Kim GW, Shin JY, Shin YG, Chung CH.

Diabetes Metab J. 2011 Apr;35(2):130-7. doi: 10.4093/dmj.2011.35.2.130. Epub 2011 Apr 30.

7.

Phage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3.

Rinderknecht M, Villa A, Ballmer-Hofer K, Neri D, Detmar M.

PLoS One. 2010 Aug 2;5(8):e11941. doi: 10.1371/journal.pone.0011941.

8.

Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia.

Hou HA, Shih TT, Liu CY, Chen BB, Tang JL, Yao M, Huang SY, Chou WC, Hsu CY, Tien HF.

Haematologica. 2010 Aug;95(8):1420-4. doi: 10.3324/haematol.2009.019364. Epub 2010 Mar 10.

9.

Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.

Lee CY, Tien HF, Hu CY, Chou WC, Lin LI.

Br J Cancer. 2007 Oct 8;97(7):877-82. Epub 2007 Sep 11.

10.

Clinical role of bone marrow angiogenesis in childhood acute lymphocytic leukemia.

Lyu CJ, Rha SY, Won SC.

Yonsei Med J. 2007 Apr 30;48(2):171-5.

11.

Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-kappaB.

Costa LF, Balcells M, Edelman ER, Nadler LM, Cardoso AA.

Blood. 2006 Jan 1;107(1):285-92. Epub 2005 Sep 1.

12.

Supplemental Content

Support Center